Novartis wins Gilenya reprieve as judge blocks generics, for now

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 25, 2019 at 9:32 AM.

  1. #1 cafead, Jun 25, 2019 at 9:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Novartis has won a U.S. federal court order preventing rival generic makers from selling versions of the Swiss drugmaker's top-selling multiple sclerosis medicine Gilenya in the United States, at least until a patent dispute is resolved.

    article source
     
    Quote

Reply to Thread